Dose-response of five bile acids on serum and liver bile acid concentrations and hepatotoxicty in mice

Toxicological Sciences

Volumn 123, Issue 2, 2011, Pages 359-367

  Song, Peizhen ^a   Zhang, Youcai ^a   Klaassen, Curtis D ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Bile acid; Dose response; Hepatotoxicity

Indexed keywords

BILE ACID; CHENODEOXYCHOLIC ACID; CHOLIC ACID; DEOXYCHOLIC ACID; LITHOCHOLIC ACID; URSODEOXYCHOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE ACID BLOOD LEVEL; BODY WEIGHT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET; GENE CONTROL; HYDROPHOBICITY; LIVER TOXICITY; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; SURVIVAL RATE; TOXICITY TESTING;

ALANINE TRANSAMINASE; ANIMALS; BILE ACIDS AND SALTS; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-INDUCED LIVER INJURY; LIVER; LONGEVITY; MALE; MICE; MICE, INBRED BALB C; ORGAN SIZE; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

MUS; RODENTIA;

EID: 80053439343     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfr177     Document Type: Article

References (29)

1. Allen, K., Jaeschke, H., and Copple, B. L. (2011). Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis. Am. J. Pathol. 178, 175-186.
2. Alnouti, Y., Csanaky, I. L., and Klaassen, C. D. (2008). Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC-MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 873, 209-217.
3. Ambros-Rudolph, C. M., Glatz, M., Trauner, M., Kerl, H., and Mullegger, R. R. (2007). The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe. Arch. Dermatol. 143, 757-762.
4. Azer, S. A., Klaassen, C. D., and Stacey, N. H. (1997). Biochemical assay of serum bile acids: methods and applications. Br. J. Biomed. Sci. 54, 118-132.
5. Billington, D., Evans, C. E., Godfrey, P. P., and Coleman, R. (1980). Effects of bile salts on the plasma membranes of isolated rat hepatocytes. Biochem. J. 188, 321-327.
6. Chiang, J. Y. (2002). Bile acid regulation of gene expression: roles of nuclear hormone receptors. Endocr. Rev. 23, 443-463.
7. Csanaky, I. L., Lu, H., Zhang, Y., Ogura, K., Choudhuri, S., and Klaassen, C. D. (2011). Organic anion-transporting polypeptide 1b2 (Oatp1b2) is important for the hepatic uptake of unconjugated bile acids: studies in Oatp1b2-null mice. Hepatology 53, 272-281.
8. Danzinger, R. G., Hofmann, A. F., Schoenfield, L. J., and Thistle, J. L. (1972). Dissolution of cholesterol gallstones by chenodeoxycholic acid. N. Engl. J. Med. 286, 1-8.
9. Delzenne, N. M., Calderon, P. B., Taper, H. S., and Roberfroid, M. B. (1992). Comparative hepatotoxicity of cholic acid, deoxycholic acid and lithocholic acid in the rat: in vivo and in vitro studies. Toxicol. Lett. 61, 291-304.
10. Deo, A. K., and Bandiera, S. M. (2008). Identification of human hepatic cytochrome p450 enzymes involved in the biotransformation of cholic and chenodeoxycholic acid. Drug. Metab. Dispos. 36, 1983-1991.
11. Fischer, S., Beuers, U., Spengler, U., Zwiebel, F. M., and Koebe, H. G. (1996). Hepatic levels of bile acids in end-stage chronic cholestatic liver disease. Clin. Chim. Acta 251, 173-186.
12. Glantz, L., Avramovich, A., Trembovler, V., Gurvitz, V., Kohen, R., Eidelman, L. A., and Shohami, E. (2005). Ischemic preconditioning increases antioxidants in the brain and peripheral organs after cerebral ischemia. Exp. Neurol. 192, 117-124.
13. Heuman, D. M. (1989). Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J. Lipid Res. 30, 719-730.
14. Hofmann, A. F. (2004). Detoxification of lithocholic acid, a toxic bile acid: relevance to drug hepatotoxicity. Drug Metab. Rev. 36, 703-722.
15. Hofmann, A. F., and Hagey, L. R. (2008). Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics. Cell. Mol. Life Sci. 65, 2461-2483.
16. Howard, D. E., and Fromm, H. (1999). Nonsurgical management of gallstone disease. Gastroenterol. Clin. N. Am. 28, 133-144.
17. Lucangioli, S. E., Castano, G., Contin, M. D., and Tripodi, V. P. (2009). Lithocholic acid as a biomarker of intrahepatic cholestasis of pregnancy during ursodeoxycholic acid treatment. Ann. Clin. Biochem. 46, 44-49.
18. Makishima, M., Lu, T. T., Xie, W., Whitfield, G. K., Domoto, H., Evans, R. M., Haussler, M. R., and Mangelsdorf, D. J. (2002). Vitamin D receptor as an intestinal bile acid sensor. Science 296, 1313-1316.
19. Palmer, R. H. (1972). Bile acids, liver injury, and liver disease. Arch. Intern. Med. 130, 606-617.
20. Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999). Bile acids: natural ligands for an orphan nuclear receptor. Science 284, 1365-1368.
21. Perez, M. J., and Briz, O. (2009). Bile-acid-induced cell injury and protection. World J. Gastroenterol. 15, 1677-1689.
22. Sato, H., Macchiarulo, A., Thomas, C., Gioiello, A., Une, M., Hofmann, A. F., Saladin, R., Schoonjans, K., Pellicciari, R., and Auwerx, J. (2008). Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies. J. Med. Chem. 51, 1831-1841.
23. Song, C., Hiipakka, R. A., and Liao, S. (2000). Selective activation of liver X receptor alpha by 6alpha-hydroxy bile acids and analogs. Steroids 65, 423-427.
24. Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J., and Schoonjans, K. (2008). Targeting bile-acid signalling for metabolic diseases. Nat. Rev. Drug Discov. 7, 678-693.
25. Tsuda, H., Masui, T., Imaida, K., Fukushima, S., and Ito, N. (1984). Promotive effect of primary and secondary bile acids on the induction of gammaglutamyl transpeptidase-positive liver cell foci as a possible endogenous factor for hepatocarcinogenesis in rats. Gann 75, 871-875.
26. Walters, J. R. (2010). Defining primary bile acid diarrhea: making the diagnosis and recognizing the disorder. Expert Rev. Gastroenterol. Hepatol. 4, 561-567.
27. Wang, D. Q., Tazuma, S., Cohen, D. E., and Carey, M. C. (2003). Feeding natural hydrophilic bile acids inhibits intestinal cholesterol absorption: studies in the gallstone-susceptible mouse. Am. J. Physiol. Gastrointest. Liver Physiol. 285, G494-G502.
28. Xie, W., Radominska-Pandya, A., Shi, Y., Simon, C. M., Nelson, M. C., Ong, E. S., Waxman, D. J., and Evans, R. M. (2001). An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc. Natl. Acad. Sci. U.S.A. 98, 3375-3380.
29. Zhang, Y., and Klaassen, C. D. (2010). Effects of feeding bile acids and a bile acid sequestrant on hepatic bile acid composition in mice. J. Lipid Res. 51, 3230-3242.SATHISH 177